Showing results (91-100 of 214) with videos related to
Sort By:
Pageof 22
The Journal of Antimicrobial Chemotherapy|April 26, 2012
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trialsMark Nelson, Gerardo Amaya, Nathan Clumeck, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2021
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource UtilizationJonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, et al.Hepatology (Baltimore, Md.)|May 24, 2012
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfectionVincent Lo Re, Jessica Volk, Craig W Newcomb, et al.Antimicrobial Agents and Chemotherapy|April 16, 2014
Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infectionKaren D Sims, Julie Lemm, Timothy Eley, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2016
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsGregory D Huhn, Pablo Tebas, Joel Gallant, et al.AIDS (London, England)|January 27, 2007
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimenMargaret A Fischl, Ann C Collier, A Lisa Mukherjee, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapyScott L Butler, Hernan Valdez, Michael Westby, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2024
Cloning and Functional Characterization of Novel Human Neutralizing Anti-IFN-α and Anti-IFN-β AntibodiesEmmanouil Papasavvas, Lily Lu, Matthew Fair, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodiesEmmanouil Papasavvas, Lily Lu, Matthew Fair, et al.AIDS (London, England)|April 28, 2015
Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adultsPablo Tebas, Sergei Spitsin, Jeffrey S Barrett, et al.Pageof 22